吡拉西坦与加兰他敏合用治疗阿尔茨海默病的作用探讨
程振田;时连亭;蒋伟立
【期刊名称】《中国医院药学杂志》 【年(卷),期】2011(031)006
【摘要】目的:探讨复方吡拉西坦时痴呆大鼠的作用并比较与吡拉西坦、加兰他敏的疗效.方法:70只Wistar大鼠随机分为假手术组,模型组,复方高、中、低剂量组,单方加兰他敏、单方吡拉西坦7个实验组,每组10只.配制吡拉西坦与加兰他敏的高、中、低3种浓度的复方制剂及其两个单方制剂,术后第2天开始,除伪手术组和模型组灌服等容积的纯化水外,其他实验组分别灌服不同剂量的药物,并于术后第9天行跳台实验,连续记录5 d成绩,第14天处死大鼠,测定脑组织中乙酰胆碱和乙酰胆碱酯酶的含量,并制作光镜标本观察海马区组织学变化.结果:与模型组和单方组比较,复方高、中剂量组可显著改善痴呆大鼠组的学习成绩,疗效优于单方给药组(P<0.01);提高脑组织乙酰胆碱的含量(P<0.05);海马区颗粒细胞排列整齐,未见明显异常.结论:复方吡拉西坦时阿尔茨海默痛的治疗效果明显优于单方用药,为两药临床合用提供实验基础.%OBJECTIVE To investigate the effect of Compound piracetam on Alzheimer's disease rats, and compared with piracetam or galantamine use alone.METHODS Seventy normal Wistar rats (male 35,female 35) were randomly divided into seven groups(n = 10)including sham-operated, model, high dose compound piracetam, medium dose compound piracetam, low dose compound piracetam, piracetam and galantamine groups.except the sham-operated and model groups were administrated with distilled
吡拉西坦与加兰他敏合用治疗阿尔茨海默病的作用探讨
